These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 17510378)
1. Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools. Kagan J; Srivastava S; Barker PE; Belinsky SA; Cairns P Cancer Res; 2007 May; 67(10):4545-9. PubMed ID: 17510378 [TBL] [Abstract][Full Text] [Related]
2. Standards for plasma and serum proteomics in early cancer detection: a needs assessment report from the national institute of standards and technology--National Cancer Institute Standards, Methods, Assays, Reagents and Technologies Workshop, August 18-19, 2005. Barker PE; Wagner PD; Stein SE; Bunk DM; Srivastava S; Omenn GS Clin Chem; 2006 Sep; 52(9):1669-74. PubMed ID: 16840585 [TBL] [Abstract][Full Text] [Related]
3. Circulating methylated DNA. Herman JG Ann N Y Acad Sci; 2004 Jun; 1022():33-9. PubMed ID: 15251936 [TBL] [Abstract][Full Text] [Related]
4. Analysis of methylated circulating DNA in cancer patients' blood. Sunami E; Vu AT; Nguyen SL; Hoon DS Methods Mol Biol; 2009; 507():349-56. PubMed ID: 18987826 [TBL] [Abstract][Full Text] [Related]
5. Stool DNA methylation assays in colorectal cancer screening. Kadiyska T; Nossikoff A World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070 [TBL] [Abstract][Full Text] [Related]
6. Blood Worth Bottling: Circulating Tumor DNA as a Cancer Biomarker. Christie EL; Dawson SJ; Bowtell DD Cancer Res; 2016 Oct; 76(19):5590-5591. PubMed ID: 27698187 [No Abstract] [Full Text] [Related]
7. Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Grady WM; Rajput A; Lutterbaugh JD; Markowitz SD Cancer Res; 2001 Feb; 61(3):900-2. PubMed ID: 11221878 [TBL] [Abstract][Full Text] [Related]
8. The early detection research network: 10-year outlook. Srivastava S Clin Chem; 2013 Jan; 59(1):60-7. PubMed ID: 23160065 [TBL] [Abstract][Full Text] [Related]
9. Methylated genes as new cancer biomarkers. Duffy MJ; Napieralski R; Martens JW; Span PN; Spyratos F; Sweep FC; Brunner N; Foekens JA; Schmitt M; Eur J Cancer; 2009 Feb; 45(3):335-46. PubMed ID: 19138839 [TBL] [Abstract][Full Text] [Related]
10. Circulating nucleic acids (CNAs) and cancer--a survey. Fleischhacker M; Schmidt B Biochim Biophys Acta; 2007 Jan; 1775(1):181-232. PubMed ID: 17137717 [TBL] [Abstract][Full Text] [Related]
11. RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA. Giannopoulou L; Chebouti I; Pavlakis K; Kasimir-Bauer S; Lianidou ES Oncotarget; 2017 Mar; 8(13):21429-21443. PubMed ID: 28206954 [TBL] [Abstract][Full Text] [Related]
12. DNA methylation of channel-related genes in cancers. Ouadid-Ahidouch H; Rodat-Despoix L; Matifat F; Morin G; Ahidouch A Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2621-8. PubMed ID: 25703813 [TBL] [Abstract][Full Text] [Related]
13. Molecular diagnostic applications of DNA methylation technology. Cottrell SE Clin Biochem; 2004 Jul; 37(7):595-604. PubMed ID: 15234241 [TBL] [Abstract][Full Text] [Related]
14. Label free colorimetric and fluorimetric direct detection of methylated DNA based on silver nanoclusters for cancer early diagnosis. Dadmehr M; Hosseini M; Hosseinkhani S; Reza Ganjali M; Sheikhnejad R Biosens Bioelectron; 2015 Nov; 73():108-113. PubMed ID: 26056954 [TBL] [Abstract][Full Text] [Related]
15. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting. Heiss JA; Brenner H Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869 [TBL] [Abstract][Full Text] [Related]
16. Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival. Balgkouranidou I; Karayiannakis A; Matthaios D; Bolanaki H; Tripsianis G; Tentes AA; Lianidou E; Chatzaki E; Fiska A; Lambropoulou M; Kolios G; Kakolyris S Clin Chem Lab Med; 2013 Jul; 51(7):1505-10. PubMed ID: 23403728 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of DNA methylation for head and neck cancer varies by sample type and number of markers tested. Ji X; Guan C; Jiang X; Li H Oncotarget; 2016 Nov; 7(48):80019-80032. PubMed ID: 27683120 [TBL] [Abstract][Full Text] [Related]
18. Assessment of DNA Integrity, Applications for Cancer Research. Zonta E; Nizard P; Taly V Adv Clin Chem; 2015; 70():197-246. PubMed ID: 26231488 [TBL] [Abstract][Full Text] [Related]
19. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients. Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472 [TBL] [Abstract][Full Text] [Related]
20. DNA methylation biomarkers and their utility for solid cancer diagnostics. Heichman KA; Warren JD Clin Chem Lab Med; 2012 Oct; 50(10):1707-21. PubMed ID: 23089699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]